IRONWOOD PHARMACEUTICALS, INC. (IRWD) Return on equity 2016–2022
IRONWOOD PHARMACEUTICALS, INC. (IRWD) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
26.8%FY2022 · since FY2016: -122.5% → 26.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | 26.8% | -60.4 pp |
| FY2021 | 87.2% | -82.3 pp |
| FY2020 | 169.5% | — |
| FY2017 | -1187.4% | -1064.9 pp |
| FY2016 | -122.5% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice